The PTEN nuclear localization regulates the tumor suppressor TP53 by a PI3K/AKT-independent mechanism, which leads to the control of cyclin D1 expression and to an increase in the ubiquitin-dependent degradation of tumor-promoting proteins, such as PLK1 and AURK [72,73]. The gene discussed is TP53; the disease is neoplasm.